Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
CD147 as a highlt specific marker for the functional subset of activated Tregs More
A gene expression profile (GEP) model has been developed for predicting cytogenetic abnormalities and thus disease progression across various types of cancers using DNA copy number analysis More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 110 pages - $1,040
Aug 2008 - 138 pages - $1,040
Aug 2010 - 138 pages - $1,215
Aug 2008 - 120 pages - $1,040
Jun 2011 - 7 pages - $500
Dec 2011 - 50 pages - $3,800
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us